Lidocaine as an anti‐arrhythmic drug: Are there any indications left?

Lidocaine as an anti‐arrhythmic drug: Are there any indications left?

Abstract Lidocaine is classified as a class Ib anti‐arrhythmic that blocks voltage‐ and pH‐dependent sodium channels. It exhibits well investigated anti‐arrhythmic effects and has been the anti‐arrhythmic of choice for the treatment of ventricular arrhythmias for several decades. Lidocaine binds pri...

Full description

Bibliographic Details
Main Authors:	Sati Güler, Hilke Könemann, Julian Wolfes, Fatih Güner, Christian Ellermann, Benjamin Rath, Gerrit Frommeyer, Philipp Sebastian Lange, Julia Köbe, Florian Reinke, Lars Eckardt
Format:	Article
Language:	English
Published:	Wiley 2023-12-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.13650

Similar Items

The Incidence, Electrophysiological Characteristics and Ablation Outcome of Left Atrial Tachycardias after Pulmonary Vein Isolation Using Three Different Ablation Technologies
by: Patrick Leitz, et al.
Published: (2022-02-01)

Pulmonary Vein Isolation in Obese Compared to Non-Obese Patients: Real-Life Experience from a Large Tertiary Center
by: Julian Wolfes, et al.
Published: (2022-08-01)

Bradycardia in Patients with Subcutaneous Implantable Defibrillators—An Overestimated Problem? Experience from a Large Tertiary Centre and a Review of the Literature
by: Kevin Willy, et al.
Published: (2022-10-01)

Sacubitril Does Not Exert Proarrhythmic Effects in Combination with Different Antiarrhythmic Drugs
by: Christian Ellermann, et al.
Published: (2025-02-01)

Safe electrophysiologic profile of dexmedetomidine in different experimental arrhythmia models
by: Christian Ellermann, et al.
Published: (2021-12-01)

Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation
by: Julian Wolfes, et al.
Published: (2020-10-01)

Corrigendum: Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts
by: Julian Wolfes, et al.
Published: (2025-02-01)

Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts
by: Julian Wolfes, et al.
Published: (2024-02-01)

The Impact of Cardiac Devices on Patients’ Quality of Life—A Systematic Review and Meta-Analysis
by: Kevin Willy, et al.
Published: (2022-08-01)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
by: Gerrit Frommeyer, et al.
Published: (2016-03-01)

Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
by: Ying Wang, et al.
Published: (2015-01-01)

Anti-Arrhythmic Potential of Coriandrum sativum Seeds in Salt Induced Arrhythmic Rats
by: Nida Rehman1, Nazish Jahan1*, Khalil-ul-Rahman2, Khalid Mahmood Khan2 and Fatiqa Zafar1
Published: (2016-11-01)

CaMKII-Dependent Contractile Dysfunction and Pro-Arrhythmic Activity in a Mouse Model of Obstructive Sleep Apnea
by: Philipp Hegner, et al.
Published: (2023-01-01)

Pseudo-arrhythmic ECG artifact
by: Satyajeet Singh, et al.
Published: (2012-01-01)

Pharmacotherapy to reduce arrhythmic mortality
by: Amit Vora, et al.
Published: (2014-01-01)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
by: Passini, E, et al.
Published: (2015)

Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T
by: Viktoria Holtstiege, et al.
Published: (2020-05-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
by: S. M. Komissarova, et al.
Published: (2021-05-01)

Management of the arrhythmic manifestations of cardiac sarcoidosis
by: Callum Cherrett, et al.
Published: (2023-05-01)

Is head injury characteristic of arrhythmic syncope?
by: Toshiyuki Furukawa, et al.
Published: (2013-08-01)

Spotlight on sudden arrhythmic death syndrome
by: Yuan D, et al.
Published: (2019-09-01)

Improvement of Retinal Microcirculation after Pulmonary Vein Isolation in Patients with Atrial Fibrillation—An Optical Coherence Tomography Angiography Study
by: Philipp S. Lange, et al.
Published: (2021-12-01)

Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
by: Johanna K. Freundt, et al.
Published: (2019-03-01)

Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes
by: Mónica Gallego, et al.
Published: (2021-07-01)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
by: Ji-Jian Chow, et al.
Published: (2024-08-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2024)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: James A. Coleman, et al.
Published: (2024-04-01)

Prolactin Inhibition to Treat Postpartum Arrhythmic Storm
by: Miriam Compagnone, MD, et al.
Published: (2024-02-01)

Myocardial and Arrhythmic Spectrum of Neuromuscular Disorders in Children
by: Anwar Baban, et al.
Published: (2021-10-01)

Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension
by: Jennifer T. Middleton, et al.
Published: (2019-07-01)

CaMKIIδ-dependent dysregulation of atrial Na+ homeostasis promotes pro-arrhythmic activity in an obstructive sleep apnea mouse model
by: Philipp Hegner, et al.
Published: (2024-06-01)

Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
by: F. Cordes, et al.
Published: (2021-02-01)

Steady-state linear harmonic vibrations of multiple-stepped Euler-Bernoulli beams under arbitrarily distributed loads carrying any number of concentrated elements
by: Klanner M., et al.
Published: (2020-06-01)

Comparison of Lidocaine-Nitroglycerine with Lidocaine for Intravenous Regional Anesthesia
by: Nadia Banihashem, et al.
Published: (2012-01-01)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
by: Chow, J, et al.
Published: (2024)

Arrhythmic Risk Stratification—General Considerations in Specific Scenarios
by: Marisa Varrenti, et al.
Published: (2024-09-01)

Cardiac resynchronization therapy: potential for arrhythmic risk modification
by: N. N. Ilov, et al.
Published: (2023-06-01)

The potential anti-arrhythmic effect of SGLT2 inhibitors
by: Hong-Yi Duan, et al.
Published: (2024-07-01)

Clock-Modulating Activities of the Anti-Arrhythmic Drug Moricizine
by: Chorong Han, et al.
Published: (2021-06-01)

Arrhythmic Mitral Valve Prolapse: A Comprehensive Review
by: Yuyan Deng, et al.
Published: (2023-09-01)